What We Monitor for AI/ML Medical Products
PCCP (Predetermined Change Control Plan)
Adaptive/continuous learning guidance
Algorithm transparency requirements
Good Machine Learning Practice (GMLP)
Clinical validation standards
Real-world performance monitoring
Bias and fairness expectations
Cybersecurity for AI/ML devices
AI/ML-specific 510(k) precedents
Decisions This Intelligence Affects
Regulatory Strategy
- • PCCP submission strategy
- • Pathway selection (510(k) vs De Novo)
- • Pre-submission meeting preparation
- • Change management planning
Product Development
- • Algorithm design decisions
- • Training data requirements
- • Validation protocol design
- • Performance monitoring systems
Quality & Compliance
- • GMLP implementation
- • Documentation requirements
- • Post-market surveillance
- • Bias monitoring protocols
Commercial & Legal
- • Transparency labeling strategy
- • Promotional claim boundaries
- • Liability considerations
- • Competitive positioning
How AI/ML Teams Use This Intelligence
Navigate PCCP Framework
Design predetermined change control plans that FDA will accept
Optimize Algorithm Design
Build adaptive systems aligned with current expectations
Accelerate Clearance
Pre-interpreted guidance reduces submission rework
Anticipate Transparency Rules
Stay ahead of labeling and disclosure requirements
Implement GMLP Confidently
Align quality systems with machine learning best practices
Document Regulatory Rationale
Support AI/ML decisions with current FDA thinking